YOUR BUSINESS AUTHORITY
Springfield, MO
Novo Nordisk announced a shortage of its Ozempic medication is expected to worsen this year.
“The supply situation for the lower strengths of Ozempic, 0.25 mg and 0.5 mg, has deteriorated with intermittent shortages for all strengths expected into Q4 2024," company officials said. "Intermittent shortages are expected into the Q4, however we continue to expand our global production capacity, which has been running 24 hours a day, seven days a week."
Novo Nordisk expects to increase its capital expenditures this year to $6.7 billion from $3.7 billion in 2023.
Read more from Quartz.
Project work in Springfield corridor will continue into 2031.
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Ozarks Farm Stop remains open after car crashes into building
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.